Canine parvovirus vaccine elicits protection from the inflammatory and clinical consequences of the disease

By Yule T.D.   Roth M.B.   Dreier K.   Johnson A.F.   Palmer-Densmore M.   Simmons K.   Fanton R.  

Vaccine, Vol. 15, Iss. 6, 1997-04 ,pp. : 720-729

Elsevier

Access to resources Recommend Favorite

Kinetics of humoral immune response after rabies VR-G oral vaccination of captive fox cubs (Vulpes vulpes) with or without maternally derived antibodies against the vaccine

By Blasco E.   Lambot M.   Barrat J.   Cliquet F.   Brochier B.   Renders C.   Krafft N.   Bailly J.   Munier M.   Pastoret P.-P.   Aubert M.F.A.  

Vaccine, Vol. 19, Iss. 32, 2001-09 ,pp. : 4805-4815

Elsevier

Access to resources Recommend Favorite

Safety, efficacy, and immunogenicity of a recombinant Osp subunit canine Lyme disease vaccine

By Jianneng M.   Hine P.M.   Clough E.R.   Fish D.   Coughlin R.T.   Beltz G.A.   Shew M.G.  

Vaccine, Vol. 14, Iss. 14, 1996-10 ,pp. : 1366-1374

Elsevier

Access to resources Recommend Favorite

Safety and immunogenicity of live, attenuated human rotavirus vaccine 89-12

By Bernstein D.I.   Smith V.E.   Sherwood J.R.   Schiff G.M.   Sander D.S.   DeFeudis D.   Spriggs D.R.   Ward R.L.  

Vaccine, Vol. 16, Iss. 4, 1998-02 ,pp. : 381-387

Elsevier

Access to resources Recommend Favorite

Contribution of dead cells to the immunogenicity of an autologous, hapten-modified melanoma vaccine

By Berd D.  

Vaccine, Vol. 21, Iss. 7, 2003-01 ,pp. : 795-797

Elsevier

Access to resources Recommend Favorite